NuVasive (NUVA) reported Q3 EPS of $0.54, in-line with the analyst estimate of $0.54. Revenue for the quarter came in at $295.3 million versus the consensus estimate of $298.74 million.
GUIDANCE:
NuVasive sees FY2022 EPS of $0.50-$0.60, versus the consensus of $2.24.